Shares of Pfizer (NYSE:PFE) traded today at $26.56, breaking its 52-week high. So far today approximately 26.6 million shares have been exchanged, as compared to an average 30-day volume of 30.2 million shares.
Potential upside of 6.0% exists for Pfizer, based on a current level of $26.46 and analysts' average consensus price target of $28.04. The stock should discover initial support at its 50-day moving average (MA) of $24.97 and subsequent support at its 200-day MA of $23.73.
Pfizer share prices have moved between a 52-week high of $26.56 and a 52-week low of $20.75 and are now trading 28% above that low price at $26.46 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has remained constant.
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.